Antonella Virtuoso Selected Research

Antonella Virtuoso Research Topics

7	Neoplasms (Cancer) 01/2024 - 07/2022
4	COVID-19 01/2024 - 12/2022
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 06/2021
2	Lung Neoplasms (Lung Cancer) 10/2023 - 07/2023
2	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2023
1	Herpes Zoster 01/2024
1	Breakthrough Infections 01/2023
1	Pathologic Complete Response 01/2023
1	Cardiotoxicity 01/2023
1	Infections 12/2022
1	Kidney Neoplasms (Kidney Cancer) 08/2013
1	Renal Cell Carcinoma (Grawitz Tumor) 08/2013
1	Prostatic Neoplasms (Prostate Cancer) 06/2013
1	Acquired Immunodeficiency Syndrome (AIDS) 05/2013

7	VaccinesIBA 01/2024 - 07/2022
5	Immune Checkpoint InhibitorsIBA 01/2024 - 09/2022
3	BNT162 VaccineIBA 01/2024 - 01/2023
3	pembrolizumabIBA 10/2023 - 06/2021
2	NivolumabIBA 10/2023 - 07/2023
1	Messenger RNA (mRNA)IBA 01/2024
1	mRNA VaccinesIBA 07/2023
1	pertuzumabIBA 01/2023
1	Trastuzumab (Herceptin)FDA Link 01/2023
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2023
1	Taxoids (Taxanes)IBA 01/2023
1	Immunoglobulin G (IgG)IBA 12/2022
1	Biomarkers (Surrogate Marker)IBA 06/2021
1	Amyloid (Amyloid Fibrils)IBA 06/2021
1	Sunitinib (Sutent)FDA Link 08/2013
1	Everolimus FDA Link 08/2013
1	cabazitaxel FDA Link 06/2013
1	Docetaxel (Taxotere)FDA Link 06/2013

5	Therapeutics 01/2024 - 05/2013
2	Time-to-Treatment 01/2023 - 01/2023
1	Modified Radical Mastectomy (Mastectomy, Modified) 01/2023
1	Neoadjuvant Therapy 01/2023
1	Castration 06/2013
1	Drug Therapy (Chemotherapy) 05/2013